Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Location » Portugal

Almada, Portugal Clinical Trials

Anemia

Site: 35120

A clinical trial seeking patients for a research study for the treatment of Anemia in Chronic Kidney Disease in Non-dialysis Patients

Arthritis and Arthritic Pain

1301.1.4005 Boehringer Ingelheim Investigational Site Updated

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

Patients are needed to participate in a clinical research study evaluating Baricitinib and Placebo for the treatment of Rheumatoid Arthritis

Investigational Site Number 620006 Updated

A clinical trial to evaluate treatments using sarilumab SAR153191 (REGN88) and placebo for patients with Rheumatoid Arthritis

Atrial Fibrillation

1160.136.17005 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Cervical Cancer

GSK Investigational Site

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

COPD (Chronic Obstructive Pulmonary Disease)

Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Heart Failure

Hospital Garcia de Orta

Patients are needed to participate in a clinical research study of ICD to evaluate Heart Failure

Hyperparathyroidism

Research Site

A Phase 3 clinical study for patients with Hyperparathyroidism, Secondary

Kidney Disease

Site: 35120

A clinical trial seeking patients for a research study for the treatment of Anemia in Chronic Kidney Disease in Non-dialysis Patients

Lung Disease

Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lupus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Research Site

A clinical trial seeking patients for a research study for the treatment of Lupus Nephritis

Lupus Nephritis

Research Site

A clinical trial seeking patients for a research study for the treatment of Lupus Nephritis

Melanoma

Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Neoplasm Metastasis

Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Research Site

A Phase 3 clinical study for patients with Hyperparathyroidism, Secondary

Nephritis

Research Site

A clinical trial seeking patients for a research study for the treatment of Lupus Nephritis

Rheumatoid Arthritis

1301.1.4005 Boehringer Ingelheim Investigational Site Updated

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

Patients are needed to participate in a clinical research study evaluating Baricitinib and Placebo for the treatment of Rheumatoid Arthritis

Investigational Site Number 620006 Updated

A clinical trial to evaluate treatments using sarilumab SAR153191 (REGN88) and placebo for patients with Rheumatoid Arthritis

Skin Cancer

Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Stroke

1160.136.17005 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Systemic Lupus Erythematosus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus